This report presents detailed analysis of the US STD market. Current scientific views on epidemiology and etiology are presented for:
AIDS/HIV
Chancroid
Chlamydia
Gonorrhea
Granuloma Inguinale
Herpes I/II
Lymphogranuloma
Mycoplasma
Papillomavirus
Syphilis
Trichomonas VaginalisThe report provides test volume and sales projections for Hospitals and Commercial/Private Labs. The report is available by section, and can be customized to specific information needs and budget. In addition to market share and sales forecasts, the report:
Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
Reviews features and operating characteristics of major analyzers used for STD testing;- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
